Most Popular Choices
Share on Facebook 4 Printer Friendly Page More Sharing Summarizing
Positive News      

When AI serves the underserved by bridging access gaps and linkage to health services

By       (Page 6 of 6 pages) Become a premium member to see this article and all articles as one long page.   No comments

Citizen News Service - CNS
Follow Me on Twitter     Message Citizen News Service - CNS
Become a Fan
  (2 fans)

"Cost of identifying one person with active TB disease is almost halved when Genki is used," said Mohit Agarwal. Cost to find 1 person with TB disease without AI was INR 106,342 (US$ 1,250) whereas the cost to find one person with TB with Genki AI reduced to INR 58,607 (US$ 688).

"More importantly we see an impact on quality of life because through the use of Genki, we are able to find patients who are sub-clinical or those who have no symptoms yet. So impact of medication is better and so is the impact on quality of life," added Mohit.

"One of the key learnings is that when the same AI product is used in different cohorts (for example, different X-Ray machines, age groups, ethnicities, genders or other such parameters) we have slightly different accuracies. For example, in different districts of Tamil Nadu we saw different accuracies of AI, however overall efficacy numbers (sensitivity and specificity numbers) remained fairly high around 92%," he said.

Responsible AI

"Responsible AI is one of the key innovations we have brought in, where while using this platform, we automatically compare the AI outcome with sputum results and radiology reviews. And we help you identify what is the efficacy of AI at your given setting and help you tune the AI to your specific setting," shared Mohit Agarwal.

With increasing deployment of AI enabled X-Rays and molecular tests in low- and middle-income countries, globally we were never so prepared ever before - for multi-disease point-of-care screening with AI and multi-disease point-of-care molecular testing using the same diagnostic infrastructure in the Global South. Let us hope all governments follow the science and evidence and help serve the underserved with equity and rights.

Shobha Shukla - CNS (Citizen News Service)

(Shobha Shukla is a feminist, health and development justice advocate, and an award-winning founding Managing Editor and Executive Director of CNS. She was also the Lead Discussant for SDG-3 at United Nations inter-governmental High Level Political Forum 2025. She is a former senior Physics faculty of prestigious Loreto Convent College; current President of Asia Pacific Regional Media Alliance for Health, Gender and Development Justice (APCAT Media); Chairperson of Global AMR Media Alliance (GAMA received the inter-ministerial AMR One Health Emerging Leaders and Outstanding Talents Award 2024); and Host of SHE & Rights (Sexual Health with Equity & Rights). Follow her on Twitter/X @shobha1shukla or read her writings here www.bit.ly/ShobhaShukla)

- Shared under Creative Commons (CC)

Next Page  1  |  2  |  3  |  4  |  5  |  6

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Rate It | View Ratings

Citizen News Service - CNS Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Citizen News Service (CNS) specializes in in-depth and rights-based, health and science journalism. For more information, please contact: www.citizen-news.org or @cns_health or www.facebook.com/cns.page
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter

Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

The chasm between TB and HIV continues

Management of respiratory diseases beyond drugs: Pulmonary Rehabilitation

Feminist world-building: Creative energies, collective journeys

Another feather in the cap of treatment as HIV prevention

Oxygen therapy is like a prescription drug: Use it rationally

New funding boosts research for controlling TB, malaria, dengue and leishmaniasis

Comments Image Post Article Comment and Rate This Article

These discussions are not moderated. We rely on users to police themselves, and flag inappropriate comments and behavior. In accordance with our Guidelines and Policies, we reserve the right to remove any post at any time for any reason, and will restrict access of registered users who repeatedly violate our terms.

  • OpEdNews welcomes lively, CIVIL discourse. Personal attacks and/or hate speech are not tolerated and may result in banning.
  • Comments should relate to the content above. Irrelevant, off-topic comments are a distraction, and will be removed.
  • By submitting this comment, you agree to all OpEdNews rules, guidelines and policies.
          

Comment Here:   


You can enter 2000 characters.
Become a Premium Member Would you like to be able to enter longer comments? You can enter 10,000 characters with Leader Membership. Simply sign up for your Premium Membership and you can say much more. Plus you'll be able to do a lot more, too.

Please login or register. Afterwards, your comment will be published.
 

Username
Password
Show Password

Forgot your password? Click here and we will send an email to the address you used when you registered.
First Name
Last Name

I am at least 16 years of age
(make sure username & password are filled in. Note that username must be an email address.)

No comments  Post Comment

 
Want to post your own comment on this Article? Post Comment


 

Tell A Friend